Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStarTakashi Yamamura, Benjamin Greenberg, de Sèze et al.|Multiple Sclerosis and Related Disorders|2022Cited by 60